Pricing Log in Create free account

BioXcel Therapeutics, Inc. (BTAIQ) vs Gelteq Limited (GELS)

BioXcel Therapeutics, Inc. and Gelteq Limited are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited is the larger, with a market value of $4.6M against $2.3M — 2.0× the size. Across the 8 metrics below, BioXcel Therapeutics, Inc. leads on 5 and Gelteq Limited on 3.

Valuation

Metric BTAIQ GELS Drug Manufacturers Specialty & Generic median
P/E n/m — 19.25
P/S 1.23 — 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 228.32 n/m 2.73
Earnings yield (12,633.33%) — (4.38%)
Free cash flow yield (5,602.20%) 0.00% 0.00%

Profitability

Metric BTAIQ GELS Drug Manufacturers Specialty & Generic median
Gross margin 53.10% — 53.94%
Operating margin (6,054.72%) — 0.00%
Net margin (9,549.87%) — 0.00%
Free cash flow margin (6,860.38%) 0.00% 0.00%
Return on equity 63.52% 0.00% (0.40%)
Return on assets (259.62%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BTAIQ GELS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (14.52%) — 10.01%
EPS growth (last fiscal year) 75.63% (62.07%) 49.06%
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BTAIQ GELS Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) 0.36 0.05
Current ratio 0.21 0.09 2.31
Net debt to EBITDA (1.61) (0.91) 0.97

Dividend

Metric BTAIQ GELS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BTAIQ GELS Drug Manufacturers Specialty & Generic median
Market cap 2.31m 4.61m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack